PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/3000/12/17
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
A case was brought by the PMCPA Director against Roche.The subject matter related to clinical trial disclosure for Gazyvaro.The case was assessed under the 2016 ABPI Code of Practice.
Clauses: NONE
🔒 Subscribers only
AUTH/2999/12/17
Data & Publications Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Otsuka
A case was brought by the PMCPA Director against Otsuka.The subject matter related to clinical trial disclosure for Deltyba.Complaint received: 20 December 2017.Applicable Code year: 2016.Case comp…
Clauses: NONE
🔒 Subscribers only
AUTH/2996/12/17
HCP Hospitality & Meetings Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Seqirus
A CCG lead prescribing support pharmacist complained about a Seqirus UK promotional email for Fluad (influenza vaccine, adjuvanted) headed “New guidance issued on adult flu vaccines”.The email …
Clauses: NONE
🔒 Subscribers only
AUTH/2985/10/17
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Sun Pharma
A lead cancer pharmacist complained about an email promotion for Sun Pharma’s gemcitabine 10mg/ml ready-to-administer (RTA) infusion bags (ref SUNUK031), promoted as “The Only Licensed Ready-To…
Clauses: NONE
🔒 Subscribers only
AUTH/2971/8/17
Off-label Promotion Upheld 🏥 Other ▶ Video 🎙 Podcast
CCG v Thame Laboratories
Two CCG staff complained about a letter Thame Laboratories sent to a clinician about prescribing Sodibic Oral Solution (sodium bicarbonate) as a food supplement instead of Thamicarb Oral Solution (…
Clauses: 2,3.2,4.2
🔒 Subscribers only
AUTH/2998/12/17
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Lilly
A matter was raised by the PMCPA Director concerning clinical trial disclosure relating to Cyramza.The case was considered under the ABPI Code of Practice (Applicable Code year: 2016).
Clauses: NONE
🔒 Subscribers only
AUTH/2967/8/17
Off-label Promotion Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Consultant v Shire
A consultant complained about Shire.The complaint alleged omission of prescribing information and other obligatory information.Case reference: AUTH/2967/8/17.Complaint received: 08 August 2017.Appl…
Clauses: NONE
🔒 Subscribers only
AUTH/2966/8/17
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Takeda
A complaint was made by a consultant against Takeda.The complaint related to the promotion of vedolizumab.The PMCPA considered the matter under the ABPI Code of Practice (applicable Code year: 2016).
Clauses: NONE
🔒 Subscribers only
AUTH/2979/9/17
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
PharmaMar
A case was brought by an anonymous, non-contactable complainant against PharmaMar.The case reference is AUTH/2979/9/17.No further factual background was provided in the supplied case text.
🔒 Subscribers only
AUTH/2939/2/17
Patient Organisations Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Astellas UK & Astellas Europe
Astellas UK and Astellas Europe made a joint voluntary admission that prescribing information (PI) used in UK promotion was incomplete for multiple medicines. The issue was discovered during routin…
Clauses: NONE
🔒 Subscribers only
AUTH/2937/2/17
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Merck Serono
An anonymous, non-contactable complainant (described as an oncology nurse specialist) complained about a Merck Serono representative promoting Erbitux (cetuximab).The complainant alleged the repres…
Clauses: NONE
🔒 Subscribers only
AUTH/2883/10/16
Social Media & Digital Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Astellas UK
Astellas UK made a voluntary admission about compliance failings linked to patient support programmes: Fresh Start (Betmiga/mirabegron) and VIP (Vesicare/solifenacin succinate).An Astellas employee…
Clauses: NONE
🔒 Subscribers only
AUTH/2922/12/16
HCP Hospitality & Meetings Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Meda
An assistant director (medicines management) complained about a Meda representative’s conduct at a GP meeting (December 2016) where the rep provided sandwiches and had ~10 minutes to speak about …
Clauses: NONE
🔒 Subscribers only
AUTH/2920/12/16
HCP Hospitality & Meetings Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
UCB
An anonymous, non-contactable ex-representative alleged UCB asked reps to promote Naloxone Minijet Injection “take-home” use (community/non-medical setting) for financial gain and target achiev…
Clauses: NONE
🔒 Subscribers only
AUTH/2918/12/16
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
A former GlaxoSmithKline (GSK) employee complained about an online cost calculator for Relvar Ellipta (fluticasone furoate/vilanterol), ref UK/FFT/0232/15(1), prepared April 2016.The complainant fo…
Clauses: NONE
🔒 Subscribers only
AUTH/2912/12/16
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Astellas Pharma Europe
Astellas Pharma Europe voluntarily admitted that three videos containing Betmiga (mirabegron) product claims had been posted online by third parties, potentially promoting a prescription-only medic…
Clauses: NONE
🔒 Subscribers only
AUTH/2908/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bayer
A CMRO transparency study (published online 25 Nov 2016) assessed whether results of company-sponsored trials linked to EMA 2013 approvals were disclosed within 12 months and by 31 Jul 2015.The PMC…
Clauses: NONE
🔒 Subscribers only
AUTH/2906/11/16
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk
A CMRO paper (ABPI-funded) assessed whether results of company-sponsored trials for EMA-approved 2013 medicines were disclosed within 12 months of the later of first regulatory approval or trial co…
Clauses: NONE
🔒 Subscribers only
AUTH/2898/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
The PMCPA Director opened a complaint after a CMRO transparency study (published 25 Nov 2016) suggested Roche had not disclosed one evaluable trial result within the required timeframe for Kadcyla …
Clauses: NONE
🔒 Subscribers only
AUTH/2893/11/16
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
GE Healthcare
An anonymous, non-contactable complainant alleged GE Healthcare promoted Vizamyl (18F flutemetamol) and/or unlicensed 18F flutemetamol injection to UK PET centres and at the EANM congress (Barcelon…
Clauses: NONE
🔒 Subscribers only
AUTH/2890/11/16
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk websites
A health professional complained about Novo Nordisk’s UK corporate website and a separate professional resource website.Concerns included: patients shown with photos and full names; diabetes pati…
Clauses: NONE
🔒 Subscribers only
AUTH/2888/11/16
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Napp
A hospital specialist nurse complained about a promotional email from Napp Pharmaceuticals Limited about switching from Remicade (originator infliximab) to Remsima (biosimilar infliximab).Email sub…
Clauses: NONE
🔒 Subscribers only
AUTH/2886/11/16
Patient Organisations Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor
Pharmacosmos complained about a Vifor Pharma UK promotional leavepiece for Ferinject (iron carboxymaltose) titled “Their world awaits” (ref UK/FER/16/0116).The front page included a red box sta…
Clauses: NONE
🔒 Subscribers only
AUTH/2887/11/16
HCP Hospitality & Meetings Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca
An anonymous, contactable complainant (described themself as a GP) complained about two AstraZeneca promotional meetings (November 2015 and November 2016) for Forxiga (dapagliflozin).The complainan…
Clauses: NONE
← Prev 31 32 33 34 35 36 37 Next → Page 34 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews